Multitargeted CAR T-cell therapy in multiple myeloma

Lancet Haematol. 2019 Oct;6(10):e494-e495. doi: 10.1016/S2352-3026(19)30165-6. Epub 2019 Aug 1.

Authors

Sandra Susanibar Adaniya¹, Alfred L Garfall²

Affiliations

¹ Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
² Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: alfred.garfall@pennmedicine.upenn.edu.

PMID: 31378663
DOI: 10.1016/S2352-3026(19)30165-6

No abstract available

Publication types

Comment

MeSH terms

Humans
Immunotherapy, Adoptive*
Multiple Myeloma*
Receptors, Antigen, T-Cell
T-Lymphocytes

Substances

Receptors, Antigen, T-Cell

Grants and funding

T32 CA009615/CA/NCI NIH HHS/United States